Stocks
Anika Therapeutics (ANIK) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| ROE, % | ? | 1.44% | -5.20% | -38.9% | -36.6% | -7.58% | -8.26% | ||
| Changes by years, y/y, % | +10pp | -7pp | -34pp | +2pp | +29pp | -17% | |||
Anika Therapeutics. ROE, %
Anika Therapeutics. ROE, changes, pp
Anika Therapeutics (ANIK) ROE US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| ROE, % | ? | -41.1% | -22.5% | -7.58% | -8.26% | -2.76% | -8.26% | |
| Changes by years, y/y, % | -6pp | +32pp | +29pp | +30pp | +38pp | |||
| Changes by quarters, q/q, % | -3pp | +19pp | +15pp | -1pp | +6pp | |||
